Extracellular ATP induces CD44 shedding from macrophage-like P388D1 cells via the P2X7 receptor

Hematological Oncology

Volumn 30, Issue 2, 2012, Pages 70-75

  Lin, Changwei ^a   Ren, Shuangyi ^a   Zhang, Li ^a   Jin, Hongfei ^a   Sun, Jianguo ^a   Zuo, Yunfei ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

ATP; CD44; P2X7R; P388D1 cell; Shedding

Indexed keywords

ADENOSINE TRIPHOSPHATE; HERMES ANTIGEN; PURINERGIC P2X7 RECEPTOR; SHORT HAIRPIN RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL LOSS; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; EXTRACELLULAR SPACE; LEUKEMIA P388; MICE; RECEPTORS, PURINERGIC P2X7;

EID: 84861824432     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.1008     Document Type: Article

References (35)

1. Ouhtit A, Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. Am J Pathol 2007; 171(6): 2033-2039.
2. Yurdakul AS, Akyürek N, Demirtaş S, Karakaya J, Memiş L, Oztürk C. The effect of adhesion molecule CEACAM1 and chemokine receptor CXCR4 expression on prognosis of non-small cell lung cancer patients. Tuberk Toraks 2010; 58(4): 351-356.
3. Li Y, Galileo DS. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion. Cancer Cell Int 2010; 10: 34.
4. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 177(4): 897-904.
5. Eisterer W, Bechter O, Söderberg O, Nilsson K, Terol M, Greil R, et al. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia. Leuk Res 2004; 28(10): 1043-1051.
6. Molica S, Vitelli G, Levato D, Giannarelli D, Gandolfo GM. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Cancer 2001; 92(4): 713-719.
7. Oh EJ, Kahng J, Kim Y, Kim M, Lim J, Kang CS, et al. Expression of functional markers in acute lymphoblastic leukemia. Leuk Res 2003; 27(10): 903-908.
8. Liu J, Jiang G. CD44 and hematologic malignancies. Cell Mol Immunol 2006; 3(5): 359-365.
9. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82(4): 1013-1067.
10. 7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol 2007; 71(1): 92-100.
11. Cho JH, Choi IS, Jang IS. P2X7 receptors enhance glutamate release in hippocampal hilar neurons. Neuroreport 2010; 21(13): 865-870.
12. Atkinson L, Milligan CJ, Buckley NJ, Deuchars J. An ATP-gated ion channel at the cell nucleus. Nature 2002; 420(6911): 42.
13. Adinolfi E, Pizzirani C, Idzko M, Panther E, Norgauer J, Di Virgilio F, et al. P2X7 receptor: death or life? Purinergic Signal 2005; 1(3): 219-227.
14. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97(3): 587-600.
15. Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 2005; 175(1): 82-89.
16. 7 receptor expression in evaluative and indolent forms of chronic B lymphocytic leukemia. Blood 2002; 99(2): 706-708.
17. Thunberg U, Tobin G, Johnson A, Söderberg O, Padyukov L, Hultdin M, et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002; 360(9349): 1935-1939.
18. Sengstake S, Boneberg EM, Illges H. CD21 and CD62L shedding are both inducible via P2X7Rs. Int Immunol 2006; 18(7): 1171-1178.
19. Moon H, Na HY, Chong KH, Kim TJ. P2X7 receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytes. Immunol Lett 2006; 102(1): 98-105.
20. Ren S, Zhang Y, Wang Y, Lui Y, Wei W, Huang X, et al. Targeting P2X7 receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes. Cell Biol Int 2010; 34(12): 1205-1211.
21. Sibalic V, Fan X, Loffing J, Wüthrich RP. Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant 1997; 12(7): 1344-1353.
22. Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest 2004; 84(7): 894-907.
23. Matsuki H, Yonezawa K, Obata K, Iwata K, Nakamura H, Okada Y, et al. Monoclonal antibodies with defined recognition sequences in the stem region of CD44: detection of differential glycosylation of CD44 between tumor and stromal cells in tissue. Cancer Res 2003; 63(23): 8278-8283.
24. Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F. Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci 1999; 112: 297-305.
25. Gu BJ, Wiley JS. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 2006; 107(12): 4946-4953.
26. Sluyter R, Wiley JS. Extracellular adenosine 5′-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors. Int Immunol 2002; 14(12): 1415-1421.
27. Drillenburg P, Pals ST. Cell adhesion receptors in lymphoma dissemination. Blood 2000; 95(6): 1900-1910.
28. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 2000; 267(6): 1550-1564.
29. la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G. Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 2003; 73(3): 339-343.
30. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97(3): 587-600.
31. Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005; 5(10): 760-771.
32. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-935.
33. Mishra JP, Mishra S, Gee K, Kumar A. Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-alpha and lipopolysaccharide-induced CD44 expression in human monocytic cells. J Biol Chem 2005; 280(29): 26825-26837.
34. Gee K, Kozlowski M, Kumar A. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells. J Biol Chem 2003; 278(39): 37275-37287.
35. Okamoto H, Oh C, Nakano K. Possible involvement of adenosine 3′:5′-cyclic monophosphate and extracellular calcium ions in histamine stimulation of interleukin-1 release from macrophage-like P388D1 cells. Immunology 1990; 70(2): 186-190.